A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins

Structure

Volumn 8, Issue 6, 2000, Pages 585-592

  Ferguson, Andrew D ^a,b   Welte, Wolfram ^a   Hofmann, Eckhard ^a   Lindner, Buko ^c   Holst, Otto ^c   Coulton, James W ^b   Diederichs, Kay ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Innate immune response; Lipopolysaccharide; Septic shock; Siderophore mediated iron acquisition; TonB dependent receptor

Indexed keywords

LIPOPOLYSACCHARIDE;

ARTICLE; BACTERIAL OUTER MEMBRANE; BINDING AFFINITY; ESCHERICHIA COLI; IMMUNE RESPONSE; LIPID ANALYSIS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI K12; EUKARYOTA; NEGIBACTERIA; PROKARYOTA;

EID: 0034660537     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(00)00143-X     Document Type: Article

References (39)

1. Mamat U., Seydel U., Grimmecke D., Holst O., Rietschel E.T. Comprehensive Natural Products Chemistry. Pinto M. 1999;179-239 Elsevier Science, Amsterdam.
2. Holst O. Endotoxin in Health and Disease. Brade H., Morrison D.C., Opal S., Vogel S. 1999;115-154 Marcel Dekker Inc, New York.
3. Zähringer U., Lindner B., Rietschel E.T. Endotoxin in Health and Disease. Brade H., Morrison D.C., Opal S., Vogel S. 1999;93-114 Marcel Dekker Inc, New York.
4. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
5. Hoffmann J.A., Kaftatos F.C., Janeway C.A. Jr., Ezekowitz R.A.B. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318.
6. Moeck G.S., Coulton J.W. TonB-dependent iron acquisition: mechanisms of siderophore-mediated active transport. Mol. Microbiol. 28:1998;675-681.
7. Ferguson A.D., Hofmann E., Coulton J.W., Diederichs K., Welte W. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 282:1998;2215-2220.
8. Raetz C.R.H. Escherichia coli and Salmonella, Cellular and Molecular Biology. Neidhardt F.C. 1996;1035-1063 American Society for Microbiology Press, Washington, DC.
9. Brandenburg K., Rietschel E.T.et al. Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharide. J. Endotoxin Res. 3:1996;173-178.
10. Locher K.P., Moras D.et al. Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes. Cell. 95:1998;771-778.
11. Nikaido H. Escherichia coli and Salmonella, Cellular and Molecular Biology. Neidhardt F.C. 1996;29-47 American Society for Microbiology Press, Washington, DC.
12. Cygler M., Rose D.R., Bundle D.R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 253:1991;442-445.
13. Kastowsky M., Sabisch A., Gutberlet T., Bradaczek H. Molecular modelling of bacterial deep rough mutant lipopolysaccharide of Escherichia coli. Eur. J. Biochem. 197:1991;707-716.
14. Guo L., Miller S.I.et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 95:1998;189-198.
15. Hwang P.M., Vogel H.J. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol. 76:1998;235-246.
16. Kaca W., de Jongh-Leuveninck J., Zähringer U., Rietschel E.T., Brade H., Verhoef J., Sinnwell V. Isolation and chemical analysis of 7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-D-manno-heptose. Carbohydrate Res. 179:1988;289-299.
17. Lindner B. Methods in Molecular Biology: Bacterial Toxins Methods and Protocols. Holst O. 2000;311-325 Humana Press Inc, Totowa, NJ.
18. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard G. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
19. Brünger A.T., Warren G.L.et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D. 54:1998;905-921.
20. Kleywegt G. Recognition of spatial motifs in protein structures. J. Mol. Biol. 285:1999;1887-1897.
21. Kraulis P. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
22. Merrit E.A., Bacon D.J. Raster3D photorealistic molecular graphics. Methods Enzymol. 277:1997;505-524.
23. Little R.G., Kelner D.N., Lim E., Burke D.J., Conlon P.J. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J. Biol. Chem. 269:1994;1865-1872.
24. Beamer L.J., Carroll S.F., Eisenberg D. The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci. 7:1998;906-914.
25. Taylor A.H., Ghrayeb J.et al. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J. Biol. Chem. 270:1995;17934-17938.
26. Lamping N., Schumann R.R.et al. Effects of site-directed mutagenesis of basic residues (Arg94, Lys95, Lys99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157:1996;4648-4656.
27. Appelmelk J., Nuijens J.H.et al. Lactoferrin is a lipid A binding protein. Infect. Immun. 62:1994;2628-2632.
28. Anderson B.F., Baker H.M., Norris G.E., Rice D.W., Baker E.N. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 Å resolution. J. Mol. Biol. 209:1989;711-734.
29. Van Berkel P.H.C., Nuijens J.H.et al. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328:1997;145-151.
30. Elass-Rochard E., Spik G.et al. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect. Immun. 66:1998;486-491.
31. Odell E.W., Sarra R., Foxworthy M., Chapple D.S., Evans R.W. Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett. 382:1996;175-178.
32. Brandenburg K., Koch M.H.J., Seydel U. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur. J. Biochem. 258:1998;686-695.
33. Artymiuk P.J., Blake C.C.F. Refinement of human lysozyme at 1.5 Å resolution. Analysis of nonbonded and hydrogen-bond interactions. J. Mol. Biol. 152:1981;733-762.
34. Blake C.C.F., Sarma V.R.et al. Structure of hen egg-white lysozyme. Nature. 206:1965;757-761.
35. Grütter M.G., Weaver L.H., Matthews B.W. Goose lysozyme structure: an evolutionary link between hen and bacteriophage lysozymes? Nature. 303:1983;828-831.
36. Matthews B.W., Remington S.J. The three-dimensional structure of the lysozyme from bacteriophage T4. Proc. Natl Acad. Sci. USA. 71:1974;4178-4182.
37. Warren H.S., Novitsky T.J.et al. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect. Immun. 60:1992;2506-2513.
38. Hoess A., Watson S., Siber G.R., Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J. 12:1993;3351-3356.
39. Ried C., Hoess A.et al. High affinity endotoxin-binding and neutralizing peptides based on the crystals structure of recombinant Limulus anti-lipopolysaccharide factor. J. Biol. Chem. 271:1996;28120-28127.